Skip to main content
. 2020 Aug 17;88(1):147–154. doi: 10.1093/neuros/nyaa335

TABLE 2.

Demographics of 1692 Patients, Stratified by mFI-5 = 0, 1, or ≥2

mFI-5 score
0 1 2 +
Characteristic Mean n (%) n (%) n (%) n (%)
Age (years) 55.5 ± 15.2 48.4 ± 14.5 59.2 ± 13.5 64.1 ± 12.7
mFI-5 0.80 ± 0.84 1692 (100%) 729 (43%) 643 (38%) 320 (19%)
Sex
 Males 807 (48%) 322 (40%) 323 (40%) 162 (20%)
 Females 885 (52%) 407 (46%) 320 (36%) 158 (18%)
Race
 Caucasian 1189 (70%) 534 (45%) 451 (38%) 204 (17%)
 African American 289 (17%) 75 (26%) 132 (46%) 82 (28%)
 Asian 94 (6%) 52 (55%) 26 (28%) 16 (17%)
 Other 120 (7%) 68 (57%) 34 (28%) 18 (15%)
Ethnicity
 Hispanic/Latino 79 (5%) 42 (53%) 31 (39%) 6 (8%)
 Not Hispanic/Latino 1613 (95%) 687 (43%) 612 (38%) 314 (20%)
Brain Tumor
 Meningioma 431 (25%) 164 (38%) 183 (42%) 84 (19%)
 High-grade glioma 319 (19%) 141 (44%) 117 (37%) 61 (19%)
 Pituitary tumor 252 (15%) 98 (39%) 99 (39%) 55 (22%)
 Brain metastasis 226 (13%) 79 (35%) 83 (37%) 64 (28%)
 Vestibular schwannoma 144 (9%) 71 (49%) 59 (41%) 14 (10%)
 Low-grade glioma 136 (8%) 83 (61%) 40 (29%) 13 (10%)
 Other 184 (11%) 93 (51%) 62 (34%) 29 (16%)